sorry, we can't preview this file

40001_2022_730_MOESM8_ESM.tif (7.36 MB)

Additional file 8 of CDK6 is upregulated and may be a potential therapeutic target in enzalutamide-resistant castration-resistant prostate cancer

figure

posted on 2022-07-04, 09:24 authored by Xi Chen, Yechen Wu, Xinan Wang, Chengdang Xu, Licheng Wang, Jingang Jian, Denglong Wu, Gang Wu

Additional file 8: Figure S7.The correlation between nine hub genes’ expression and the prognosis of PCa in OS status got from GEPIA online tool. A GRIP2 B EPHB2 C CDK6 D PAX6 E BMP7 F ITGA1 G LAMB1 H IGFBP5 I LY6K.

Funding

Clinical Research Plan of SHDC New Frontier Technology Joint Research Project of Shanghai Municipal Hospital Clinical project of Shanghai Municipal Health Commission Natural Science Foundation of Shanghai Municipal Science and Technology Committee National Natural Science Foundation of China Shanghai Municipal Health Commission

History

Usage metrics

Keywords

Differentially expressed genes Castration-resistant prostate cancer Enzalutamide Hub gene Cyclin-dependent kinase 6 Therapeutic target

Licence

CC BY + CC0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM